Literature DB >> 8506667

[24-hour monitoring of blood pressure in patients with essential hypertension].

J Siegelová1, B Fiser, J Dusek, B Semrád, F Halberg, G Cornelissen.   

Abstract

The aim of the study was to determine the efficiency of enalapril therapy during 24-hours blood pressure monitoring. A group of healthy subjects (C, n = 11), a group of patients with essential hypertension without therapy (EH, n = 9) and a group of patients with essential hypertension II (WHO) treated with enalapril (Acepril Lachema) in once a day doses (13.0 +/- 2.1 mg per kg) during at least 10 months (EH A, n = 8). In all groups of patients and healthy subjects 24-hours blood pressure measurement was provided using Accutracker II equipment. The mean values of systolic (SBP) and diastolic blood pressure (DBP) from 24-hours measurement (+/- SD) were in the group of healthy subjects C 121.38 +/- 10.49/74.79 +/- 7.88 mmHg, in the group EH 146.58 +/- 12.20/88.0 +/- 8.97 mmHg, in the group EH A 127.38 +/- 8.36/74.71 +/- 6.08 mmHg. The differences between the maximum and minimum mean blood pressure values during 24 hours (SBP/DBP) were in the group C 33/27 mmHg, EH 37/29 mmHg, EH A 29/21 mmHg. The smaller difference in SBP and DBP in EH A patients was significant in comparison to C and EH (t-test, p < 0.05). Cosinor analysis proved the results. From our results we can conclude that the Acepril therapy decreases blood pressure more during the day-hours then during night and it is preferable in connection to the risk of night hypotension with hypoxia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8506667

Source DB:  PubMed          Journal:  Vnitr Lek        ISSN: 0042-773X


  2 in total

1.  ANALYSIS OF BAROREFLEX FUNCTION BY MEANS OF MATHEMATICAL MODEL.

Authors:  B Fišer; J Siegelová; M Pohanka; M Mašek; J Barák; J Moudr; C Cornélissen; F Halberg
Journal:  Scr Med (Brno)       Date:  2007-10-01

2.  CIRCADIAN BLOOD PRESSURE VARIABILITY AND EXERCISE THERAPY.

Authors:  A Havelková; J Siegelová; B Fišer; L Mífková; V Chludilová; J Pochmonová; P Vank; M Pohanka; J Dušek; G Cornélissen; F Halberg
Journal:  Scr Med (Brno)       Date:  2007-11-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.